Top Medical News
22 hours ago
Topical and oral azithromycin present effective options for the treatment of meibomian gland dysfunction (MGD), reports a recent meta-analysis.
Audrey Abella, 2 days ago
The pupil of the eye may independently predict all‐cause mortality and readmission due to heart failure (HF), suggesting its prognostic predictive capability in patients with HF, a retrospective analysis has shown.
6 days ago
Glaucomatous macular damage appears to impair the ability of patients to recognize faces, a study has found. This is despite having good visual acuity.
16 Sep 2020
Visual axis opacity (VAO) frequently occurs following intraocular lens (IOL) implantation in early childhood, a recent study has found.
Stephen Padilla, 16 Sep 2020
An artificial intelligence (AI) dashboard for examining glaucomatous functional loss, developed using a large visual field (VF) dataset containing a broad spectrum of visual deficit types, provides clinicians with a user-friendly tool to determine the severity of glaucomatous vision deficit and the spatial extent of the damage, as well as monitor disease progression, reports a study.
15 Sep 2020
Increased dietary intake of multiple nutrients, such as minerals, vitamins, and carotenoids, protects against the risk of progression to late age-related macular degeneration, specifically geographic atrophy, according to a study.
12 Sep 2020
The risk of developing myopic macular degeneration (MMD) is high among older individuals, women, those with lower education, greater myopia severity, and longer axial length, according to data from a consortium of Asian studies. Furthermore, myopic spherical equivalent is the strongest single predictor of MMD.
Special Reports
Dr. David Eichenbaum, Dr. Dilsher Dhoot, Prof. Peter Campochiaro, Dr. Timothy Y Y Lai, 04 Sep 2020

Intravitreal injection of antiangiogenic agents is the standard of care for neovascular age-related macular degeneration (nAMD), however, frequent injections represent a considerable treatment burden for patients. Results of the Ladder and Archway studies, presented at the 38th Annual Meeting of the American Society of Retina Specialists (ASRS 2020), showed that administration of ranibizumab through a port delivery system (PDS) considerably reduced treatment burden, while maintaining comparable efficacy and safety vs intravitreal injections. In an interview with MIMS Doctor, Dr Timothy Lai of Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, discusses how PDS may transform the management of nAMD.

Roshini Claire Anthony, 28 Jun 2020

Roxadustat treatment for anaemia in patients with dialysis-dependent chronic kidney disease (DD CKD) does not come with an increased risk of ophthalmic abnormalities, according to a phase III trial conducted in Japan.